MOH — authorised 6 April 2011
- Marketing authorisation holder: IPR PHARMS INC
- Status: likely_approved
🇮🇱 Caprelsa in Israel
MOH authorised Caprelsa on 6 April 2011
Marketing authorisation
Caprelsa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Caprelsa approved in Israel?
Yes. MOH authorised it on 6 April 2011.
Who is the marketing authorisation holder for Caprelsa in Israel?
IPR PHARMS INC holds the Israeli marketing authorisation.